Affiliation:
1. Research Centre for Molecular Medicine MTA‐DE Lendület Vascular Pathophysiology Research Group, Faculty of Medicine University of Debrecen Debrecen Hungary
2. Doctoral School of Molecular Cell and Immune Biology University of Debrecen Debrecen Hungary
3. Department of Pharmaceutical Technology Faculty of Pharmacy University of Debrecen Debrecen Hungary
Abstract
AbstractCataract, a leading cause of blindness, is characterised by lens opacification. Type 2 diabetes is associated with a two‐ to fivefold higher prevalence of cataracts. The risk of cataract formation increases with the duration of diabetes and the severity of hyperglycaemia. Hydroxyapatite deposition is present in cataractous lenses that could be the consequence of osteogenic differentiation and calcification of lens epithelial cells (LECs). We hypothesised that hyperglycaemia might promote the osteogenic differentiation of human LECs (HuLECs). Osteogenic medium (OM) containing excess phosphate and calcium with normal (1 g/L) or high (4.5 g/L) glucose was used to induce HuLEC calcification. High glucose accelerated and intensified OM‐induced calcification of HuLECs, which was accompanied by hyperglycaemia‐induced upregulation of the osteogenic markers Runx2, Sox9, alkaline phosphatase and osteocalcin, as well as nuclear translocation of Runx2. High glucose‐induced calcification was abolished in Runx2‐deficient HuLECs. Additionally, high glucose stabilised the regulatory alpha subunits of hypoxia‐inducible factor 1 (HIF‐1), triggered nuclear translocation of HIF‐1α and increased the expression of HIF‐1 target genes. Gene silencing of HIF‐1α or HIF‐2α attenuated hyperglycaemia‐induced calcification of HuLECs, while hypoxia mimetics (desferrioxamine, CoCl2) enhanced calcification of HuLECs under normal glucose conditions. Overall, this study suggests that high glucose promotes HuLEC calcification via Runx2 and the activation of the HIF‐1 signalling pathway. These findings may provide new insights into the pathogenesis of diabetic cataracts, shedding light on potential factors for intervention to treat this sight‐threatening condition.